247 related articles for article (PubMed ID: 32710953)
1. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.
Huang SS; Ding DF; Chen S; Dong CL; Ye XL; Yuan YG; Feng YM; You N; Xu JR; Miao H; You Q; Lu X; Lu YB
Sci Rep; 2017 Apr; 7():45692. PubMed ID: 28374806
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.
Chang CC; Chang CY; Wu YT; Huang JP; Yen TH; Hung LM
J Biomed Sci; 2011 Jun; 18(1):47. PubMed ID: 21699681
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
Kitada M; Kume S; Imaizumi N; Koya D
Diabetes; 2011 Feb; 60(2):634-43. PubMed ID: 21270273
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol decreases high glucose‑induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress.
Zhang J; Dong XJ; Ding MR; You CY; Lin X; Wang Y; Wu MJ; Xu GF; Wang GD
Mol Med Rep; 2020 Nov; 22(5):4367-4375. PubMed ID: 33000199
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
He T; Xiong J; Nie L; Yu Y; Guan X; Xu X; Xiao T; Yang K; Liu L; Zhang D; Huang Y; Zhang J; Wang J; Sharma K; Zhao J
J Mol Med (Berl); 2016 Dec; 94(12):1359-1371. PubMed ID: 27488452
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress.
Zhang T; Chi Y; Kang Y; Lu H; Niu H; Liu W; Li Y
J Cell Physiol; 2019 Apr; 234(4):5033-5043. PubMed ID: 30187480
[TBL] [Abstract][Full Text] [Related]
10. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4.
Zhang J; Yang S; Li H; Chen F; Shi J
Eur J Pharmacol; 2017 Jun; 804():1-6. PubMed ID: 28395989
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
12. Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
Cui FQ; Wang YF; Gao YB; Meng Y; Cai Z; Shen C; Liu ZQ; Jiang XC; Zhao WJ
J Diabetes Res; 2019; 2019():9512406. PubMed ID: 31886291
[TBL] [Abstract][Full Text] [Related]
13. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway.
Tian H; Zheng X; Wang H
Int Urol Nephrol; 2023 Feb; 55(2):423-436. PubMed ID: 35960477
[TBL] [Abstract][Full Text] [Related]
14. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
15. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
[TBL] [Abstract][Full Text] [Related]
16. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
[TBL] [Abstract][Full Text] [Related]
17. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
[TBL] [Abstract][Full Text] [Related]
19. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.
Liang Y; Liu H; Fang Y; Lin P; Lu Z; Zhang P; Jiao X; Teng J; Ding X; Dai Y
J Cell Mol Med; 2021 Jan; 25(2):1012-1023. PubMed ID: 33332718
[TBL] [Abstract][Full Text] [Related]
20. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
